Global Recombinant Protein Therapeutics Cdmo Market Size & Outlook
The recombinant protein therapeutics cdmo industry worldwide is expected to reach a projected revenue of US$ 51,954.2 million by 2030. A compound annual growth rate of 13.9% is expected of the worldwide recombinant protein therapeutics cdmo industry from 2024 to 2030.
Revenue, 2023 (US$M)
$20,891.0
Forecast, 2030 (US$M)
$51,954.2
CAGR, 2024 - 2030
13.9%
Report Coverage
Worldwide
Global recombinant protein therapeutics cdmo market, 2018-2030 (US$M)
Related Markets
Global recombinant protein therapeutics cdmo market highlights
- The global recombinant protein therapeutics cdmo market generated a revenue of USD 20,891.0 million in 2023 and is expected to reach USD 51,954.2 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 13.9% by 2030.
- In terms of segment, interferons accounted for a revenue of USD 4,483.5 million in 2023.
- Growth Hormones is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 20,891.0 million |
| Market revenue in 2030 | USD 51,954.2 million |
| Growth rate | 13.9% (CAGR from 2023 to 2030) |
| Largest segment | Interferons |
| Fastest growing segment | Growth Hormones |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Growth Hormones, Interferons, Vaccines, Immunostimulating Agents |
Other key industry trends
- In terms of revenue, the North America accounted for 38.5% of the global recombinant protein therapeutics cdmo market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 107.7 million by 2030.
Interferons was the largest segment with a revenue share of 21.46% in 2023. Horizon Databook has segmented the Global recombinant protein therapeutics cdmo market based on growth hormones, interferons, vaccines, immunostimulating agents covering the revenue growth of each sub-segment from 2018 to 2030.
Can be influenced by increasing R&D activities, facility expansions, and growing disease burden. Analyzing market influencers involves innovation, acquisitions, and presence of pharmaceutical and biotech firms.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Protein Therapeutics CDMO Market Scope
Recombinant protein therapeutics cdmo market segmentation & scope
Others
Recombinant Protein Therapeutics CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global recombinant protein therapeutics cdmo market size, by region, 2018-2030 (US$M)
Top 10 countries: Recombinant protein therapeutics cdmo market size, 2023 (US$M)
Global recombinant protein therapeutics cdmo market share, by type, 2023 & 2030 (%, US$M)
Recombinant protein therapeutics cdmo market: Opportunity assessment by country
Global recombinant protein therapeutics cdmo market, by region, 2023 (US$M)
| Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4,338.3 | 4,844.8 | 5,584.4 | 6,303.2 | 7,108.3 | 8,051.6 | 9,128.2 | 10,357.8 | 11,763.4 | 13,371.5 | 15,212.7 | 17,322.7 | 19,742.6 | 13.7% |
| Europe | 3,180.1 | 3,563.3 | 4,121.1 | 4,667.2 | 5,281.0 | 6,001.9 | 6,827.3 | 7,773.1 | 8,857.6 | 10,102.3 | 11,532.0 | 13,175.6 | 15,066.7 | 14.1% |
| Asia Pacific | 2,838.2 | 3,188.5 | 3,697.2 | 4,197.9 | 4,762.4 | 5,426.6 | 6,188.8 | 7,064.4 | 8,070.9 | 9,229.0 | 10,562.5 | 12,099.3 | 13,871.8 | 14.4% |
| Latin America | 425.5 | 472.7 | 542.1 | 608.6 | 682.8 | 769.3 | 867.6 | 979.4 | 1,106.4 | 1,251.1 | 1,416.0 | 1,603.9 | 1,818.4 | 13.1% |
| MEA | 361.1 | 400.0 | 457.3 | 511.7 | 571.8 | 641.6 | 720.2 | 808.9 | 908.8 | 1,021.6 | 1,148.9 | 1,292.6 | 1,454.7 | 12.4% |
| Overall | 11,143.2 | 12,469.2 | 14,402.0 | 16,288.7 | 18,406.2 | 20,891.0 | 23,732.2 | 26,983.5 | 30,707.2 | 34,975.5 | 39,872.1 | 45,494.1 | 51,954.2 | 13.9% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
